Cannabis Legalization Linked to Increased Cardiovascular Hospitalizations, Study Finds
A new study suggests a rise in heart conditions and attacks following the legalization of recreational marijuana in Western U.S. states.
Recreational cannabis legalization in the United States has been associated with an increase in hospital admissions for several cardiovascular diseases, according to a new study published in BMJ Open. Researchers analyzed over 50 million hospital discharge records from 2012 to 2018 and found that admissions for conditions such as atrial fibrillation, heart failure, and heart attacks rose more rapidly in Western U.S. states after recreational marijuana laws were enacted, compared to regions without similar legislation.
Cardiovascular Health Trends Post-Legalization
The study, which is described as the first of its kind to examine the link between recreational cannabis legalization and cardiovascular hospitalizations, observed specific trends in patient demographics and admission rates. Patients hospitalized for these conditions were, on average, 51 years old, slightly younger than those in regions without legalization. They were also more likely to reside in higher-income ZIP codes and less likely to identify as white.
Prior to the implementation of recreational cannabis laws, hospitalization rates for these conditions were lower in the Western region than in non-legalizing areas. However, following legalization, the rates increased more sharply. The study reported a nearly 2% faster increase for atrial fibrillation, close to 4% for heart failure, and over 3% for heart attacks in the Western states.
Potential Mechanisms and Study Limitations
Researchers suggest that cannabis may impact cardiovascular health through several physiological pathways. These include elevated heart rate, blood pressure fluctuations, potential for blood clot formation, and chest pain. The study also notes that increased cannabis use, particularly among older adults who are already at higher risk for cardiovascular issues, may contribute to these trends.
The research focused on 13 Western states that began legalizing recreational cannabis in 2014. By 2018, a significant portion of the population in this region lived in or near states with legal cannabis sales, providing a suitable context for the study. The researchers monitored hospitalizations for acute heart failure, heart attack, atrial fibrillation/flutter, ischemic stroke, venous thromboembolism (VTE), and ventricular tachycardia.
The study acknowledges limitations, including its observational nature, which prevents the establishment of direct causality. The researchers could not analyze state-by-state trends, differentiate between methods of cannabis consumption, or account for illicit cannabis use. Despite these limitations, the findings suggest a potential link between recreational cannabis legalization and adverse population health outcomes related to cardiovascular health.